Drug intelligence / Profile preview

MucoBoost

Development stage
Unknown
Lead developer
Lovaltech
Modality
Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intranasal
01

Overview

MucoBoost (LVT001) is an intranasal, adjuvant-free protein subunit vaccine developed by Lovaltech in collaboration with the BioMap laboratory (Tours University and INRAE). The vaccine is based on a fusion protein, SwFN, which combines the SARS-CoV-2 Spike protein and Nucleoprotein to elicit a broad-spectrum immune response against multiple viral variants. By utilizing a nanocarrier-based mucosal delivery system, MucoBoost aims to induce local respiratory immunity, potentially blocking both infection and transmission of the virus. It is currently in Phase 2 clinical trials (NCT06821126) for the prevention of COVID-19.

Brand names
MucoBoost
Other names
LVT001LVT-001LVT 001
02

Targets

FcγR (Fc gamma receptor)SARS-CoV-2 spike

Beyond the preview

Go deeper on MucoBoost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MucoBoost.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call